Navigation Links
Biocept to Hold 2015 Third Quarter Conference Call on November 5
Date:10/29/2015

SAN DIEGO, Oct. 29, 2015 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a molecular diagnostics company commercializing and developing blood-based liquid biopsies to improve the detection and treatment of cancer, announces that it will release financial results for the quarter ended September 30, 2015 after market close on Thursday, November 5, 2015.  Biocept management will hold an investment community conference call at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss those results and answer questions.

Individuals interested in participating on the conference call may do so by dialing (877) 870-4263 for domestic callers, (855)-669-9657 for Canadian callers, or (412) 317-0790 for other international callers. Those interested in listening to a webcast of the live conference call may do so by visiting http://ir.biocept.com/events.cfm.

A replay of the conference call will be available for 48 hours following the conclusion of the call by dialing (877) 344-7529 for domestic callers, (855) 669-9658 for Canadian callers, or (412) 317-0088 for other international callers, and entering replay access code 10074637. A webcast replay will be available for 90 days at http://ir.biocept.com/events.cfm.

About Biocept

Biocept, Inc. is a commercial-stage molecular diagnostics company that utilizes a proprietary technology platform and a standard blood sample to provide physicians with important prognostic and predictive information to enhance individual treatment of patients with cancer. Biocept's technology platform captures and analyzes circulating tumor DNA, both in CTCs and in plasma (ctDNA). Biocept currently offers assays for lung, breast, colon and gastric cancers as well as melanoma, and plans to introduce CLIA-validated tests for other solid tumors in the near term. More information is available at www.biocept.com

Logo - http://photos.prnewswire.com/prnh/20151013/276540LOGO

 


'/>"/>
SOURCE Biocept, Inc.
Copyright©2015 PR Newswire.
All rights reserved


Related biology technology :

1. Bayer CropScience Hosts Third Sustainability in Agriculture: A Bayer Executive Course
2. PAREXEL Announces Date of Third Quarter Fiscal Year 2013 Earnings Release and Conference Call
3. At Three Months Post Launch, Two-Thirds of Surveyed U.S. Rheumatologists Believe that Initiations of Pfizers Xeljanz in the Rheumatoid Arthritis Treatment Algorithm Will Occur Following at Least Two Biologic Failures
4. Techne Corporation Releases Unaudited Third Quarter And Nine Month Fiscal Year 2013 Results
5. PAREXEL International Reports Third Quarter Fiscal Year 2013 Results
6. Palatin Technologies, Inc. To Report Fiscal Year 2013 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2013
7. Palatin Technologies Announces Third Quarter Fiscal Year 2013 Results and Update on Development of Bremelanotide for Female Sexual Dysfunction
8. Dr. Ritchie Shoemaker Certifies Third Physician in His Treatment Protocol for Chronic Inflammatory Response Syndrome (CIRS)
9. Hadasit Bio-Holdings Ltd. to Present at the Third Annual Connecticut-Israel Technology Summit
10. Case Western Reserve University, in Collaboration with NDI Medical, SPR Therapeutics and Valtronic Technologies, Receives $3 Million from Ohio Third Frontier Commission
11. Aviir Secures Third $10 Million Financing Tranche To Fund Expanded Sales Of New Heart Risk Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2020)... ... March 03, 2020 , ... Frictionless Solutions, a specialized ... industries, was recognized by INC. 5,000 on an annual list of America’s fastest ... leaders greatly impacting their spheres of influence and experiencing considerable development. INC. 5,000’s ...
(Date:3/2/2020)... FREDERICK, Md. (PRWEB) , ... March 02, 2020 , ... ... Top Patent Firms 2019 list in the field of Biotechnology and Organics. , According ... counsel on a total of 259 patents issued in technology center 1600 during 2019. ...
(Date:2/26/2020)... Del. (PRWEB) , ... February 25, 2020 , ... ... DuPont Nutrition & Biosciences (DuPont) recently published the results of its safety assessment ... over 130 HMOs currently identified in human milk. These complex carbohydrates are indigestible ...
(Date:2/21/2020)... TORONTO (PRWEB) , ... February ... ... demonstrates an exquisite capability to perform complex, efficient and elegant chemistry. Humans ... and algorithms to our own goals. , Through rapidly evolving technologies and ...
Breaking Biology Technology:
(Date:3/5/2020)... , ... March 05, 2020 , ... ... a strategic partnership agreement with Phoenestra GmbH to accelerate Cytonus’ existing products and ... in San Diego, California. Phoenestra is a biotech company located in Austria. ...
(Date:3/4/2020)... ... March 04, 2020 , ... Vitamin Science, Inc, ... a unique, multi-dimensional nutraceutical formula for ocular blue light protection. , VisiVite ... to increase the retina’s healthy pigmentation and improve the eye’s management of high ...
(Date:3/3/2020)... ... 03, 2020 , ... Board-certified oral and maxillofacial surgeon, Dr. Michael Noffze offers ... training and experience, Dr. Noffze can successfully extract problem and impacted wisdom teeth in ... is beneficial to the oral and overall health of most patients as these extra ...
Breaking Biology News(10 mins):